DOLF’s 2024 Year in Review
We are pleased to share a summary of our accomplishments of the past year.
Field Note: Portable qPCR thermocycler enables fast track xenomonitoring of mosquito vectors for DNA of the filarial parasite Brugia malayi in Indonesia
In December 2024, Dr. Irina Diekmann, a postdoctoral researcher at Washington University School of Medicine (WashU Med) joined Professor Taniawati Supali and her team at Universitas Indonesia (UI) in Jakarta, Indonesia. Irina travelled with a portable qPCR machine. While the laboratory in Jakarta already had access to real-time PCR equipment, standardization of assays was a […]
DOLF Leadership Visits Clinical Trial Sites in Liberia and Ivory Coast
The DOLF Project PI, Dr. Peter Fischer, and associate director Laura Peer traveled to Liberia in October for a mid-trial visit the site of DOLF’s clinical trial of treatment for the neglected tropical disease (NTD) onchocerciasis (also known as “river blindness”). The clinical trial is located at Bong Mines Hospital about 70 miles from the […]
New Assay to Detect Loa Loa Antigen Moves Closer to Development of Rapid Diagnostic Test
Loiasis is a filarial infection of millions of people in western Africa. In addition to the morbidity caused by this infection, the presence of loiasis significantly complicates global health campaigns to eliminate two neglected tropical diseases- lymphatic filariasis and onchocerciasis. When people with a high burden of Loa loa microfilaria (the causative agent of loiasis) are […]
DOLF Says Goodbye to Postdoctoral Research Associate Dr. Adebiyi Adeniran
We would like to announce that Postdoctoral Research Associate Dr. Adebiyi Adeniran transitioned out of his role with DOLF at the end of August. While we are saddened to see him go, we are excited about his future opportunities. During his two years with DOLF, Adebiyi made significant contributions to our lab by using molecular […]